120 / 220
1 1 6
fInanCIal StatementS
STATEMENTS OF CASH FLOWS
F O R T H E Y E A R E N D E D 3 1 M A R C H 2 0 1 8
Group
Company
2018
2017
2018
2017
RM’000
RM’000
RM’000
RM’000
Cash flows from operating activities
Profit before tax
80,484
84,672
42,697
54,300
Adjustment for:
Amortisation of biological assets
3,893
6,450
-
-
Depreciation
- Property, plant and equipment
19,113
25,755
597
653
- Investment properties
1,635
1,633
37
34
Dividend income
-
-
(41,223)
(52,317)
Impairment loss on:
- property, plant and equipment
832
4,646
-
-
- biological assets
-
24,779
-
-
- trade receivables
55
111
-
-
- other receivables
368
3,991
9
-
Interest expense
1,500
748
1,560
420
Interest income
(8,945)
(8,792)
(10,585)
(9,649)
Distribution from short term cash investments
(457)
-
(3)
-
Negative goodwill on acquisition of subsidiaries
(275)
-
-
-
Net gain on disposal of property, plant and equipment
(108)
(2)
(4)
(2)
Net unrealised forex loss
8,438
3
-
-
Provision for retirement benefits
289
284
-
-
Net reversal of provision for warranty
(4,866)
(2,287)
-
-
Share of results of associates
475
(2,861)
-
-
Share and options granted under ESS
-
43
-
43
Write back of impairment loss on:
- trade receivables
(265)
(1,498)
-
-
- other receivables
(2,534)
-
-
-
- amount due from a subsidiary
-
-
-
(150)
Write down of inventories
2,484
2,462
-
-
Write off of biological assets
-
70
-
-
Operating profit/(loss) before working capital changes
102,116
140,207
(6,915)
(6,668)
Decrease in inventories
2,904
4,101
-
-
(Increase)/decrease in receivables
(24,969)
60,425
(646)
(74)
Increase in net amount due from related companies
-
-
(21,185)
(37,845)
(Decrease)/increase in payables
(56,371)
25,606
401
84